GregoryTheGibor Posted - 39 minutes ago

$VYGR fk is you doing b!tch? why wont this fill my order at $5.00????

Stocks4thought Posted - 22 hours ago

$ELDN Should Scoot soon .50 cent move (no relation to the rapper).............................ot $SLNO $ALT $BWAY $VYGR

briefingcom Posted - 1 day ago

$VYGR: Voyager Therapeutics has selected a lead development candidate, VY1706, for its tau silencing gene therapy program in Alzheimer’s disease https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241120071924VYGR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

DonCorleone77 Posted - 1 day ago

$VYGR Voyager Therapeutics selects VY1706 for program in Alzheimer's Disease Voyager Therapeutics announced that it has selected a lead development candidate, VY1706, for its tau silencing gene therapy program in Alzheimer's disease. The Company anticipates filing an investigational new drug, IND, application with the U.S. Food and Drug Administration and a clinical trial application, CTA, with Health Canada for VY1706 in 2026. "The nomination of this tau silencing development candidate VY1706, along with the ongoing clinical trial of our anti-tau antibody VY7523, demonstrate our conviction that tau is an important target in Alzheimer's disease," said Toby Ferguson, M.D., Ph.D., Chief Medical Officer of Voyager. "We have seen third-party data indicating that both a tau antibody and a tau knockdown approach can impact tau accumulation in a human brain, and that this may correlate with clinical benefit. We will continue to assess and learn from emerging data in this field as we efficiently progress our differentiated tau antibody and tau gene therapy programs towards human proof-of-concept."

_Village_Idiot_ Posted - 1 day ago

$VYGR Trading below cash value and long runway. Yea, I’m loading. Please and thank you homies.

metrostock Posted - 3 days ago

$VYGR RFK jr nominee

Mmmyes Posted - 5 days ago

$VYGR not sure why this dropped when the earnings report was so strong. Anyone have insight?

kenny91655 Posted - 5 days ago

$VYGR loading LRMR and VYGR

_Village_Idiot_ Posted - 5 days ago

$VYGR Loading heavy on $7.50C Jan 2025

somewon Posted - 5 days ago

$VYGR trading below cash now

SpacePillgreem Posted - 6 days ago

$VYGR Voyager Therapeutics recently reported its Q3 2024 financial results. Key highlights include a significant increase in collaboration revenue to $24.6 million, primarily due to agreements with Novartis and Neurocrine. The company’s net loss decreased to $9.0 million, reflecting higher collaboration revenue. Research and development expenses rose to $30.2 million due to increased hiring and facility costs. Voyager’s cash position remains strong at $345.4 million, expected to sustain operations into 2027. Upcoming milestones include clinical data releases and regulatory filings in 2025. In addition to the financials and pipeline progress, Voyager Therapeutics has presented promising preclinical data for its VY7523 tau antibody program. Voyager is also preparing to file an IND for its SOD1 silencing gene therapy in ALS patients by mid-2025, with several other gene therapy programs advancing towards clinical trials.

Jlab56 Posted - 6 days ago

$VYGR pos stock

NoRisksNoFun Posted - 1 week ago

$VYGR $ALT $sava to all sava holders wenn it fails, you have still another brilliant Alzheimer’s play $VYGR !!!

Dombak Posted - 1 week ago

$VYGR listening to this call, reading the results and surprised at such a muted reaction after hours. Results like this increase the the value of the company by 30-40% IMO.

DonCorleone77 Posted - 1 week ago

$VYGR Voyager has sufficient resources for planned operating expenses into 2027 Voyager is committed to maintaining a strong balance sheet that supports the advancement and growth of its platform and pipeline. Voyager continues to assess its planned cash needs both during the current period and in future periods. We expect our cash, cash equivalents, and marketable securities, along with amounts expected to be received as reimbursement for development costs under the Neurocrine and Novartis collaborations and interest income, to be sufficient to meet Voyager's planned operating expenses and capital expenditure requirements into 2027.

DonCorleone77 Posted - 1 week ago

$VYGR Voyager Therapeutics reports Q3 EPS (16c), consensus (45c) Reports Q3 revenue $ $24.6M , consensus $11.89M."An increasing body of clinical evidence implicates tau as a critical target in Alzheimer's disease," said Alfred W. Sandrock, Jr., M.D., Ph.D., Chief Executive Officer of Voyager. "Recent third-party clinical data give us increasing confidence that an antibody targeting the appropriate epitope of tau can slow the accumulation of tau in the brain of Alzheimer's patients, and that this slowing may offer a clinically significant benefit in some patients. These encouraging data build on previous positive third-party clinical data with a tau silencing program and, we believe, support Voyager's prioritization of both an anti-tau antibody and a tau silencing gene therapy. Our clinical-stage anti-tau antibody VY7523 is expected to generate initial tau PET imaging data in patients in H2 2026, and our tau silencing gene therapy is advancing toward IND in 2026. Our strong cash position of $345 million is expected to provide runway into 2027, enabling multiple data readouts."

NoRisksNoFun Posted - 1 week ago

$VYGR $alt this is huge heat!

lecorb Posted - 1 week ago

$VYGR Voyager Therapeutics GAAP EPS of -$0.16 beats by $0.29, revenue of $24.63M beats by $12.93M

NoRisksNoFun Posted - 1 week ago

$SGMO $VKTX $VYGR $ALT

dmoney9975 Posted - 1 week ago

$SGMO been loading up for years here. What should I be looking at next? Thinking $VKTX or $VYGR

NoRisksNoFun Posted - 2 weeks ago

$VYGR $VKTX who found any news about voyager??

metrostock Posted - 2 weeks ago

$VYGR should be at 9.00

somewon Posted - 2 weeks ago

$VYGR trading at cash value, yet they keep making deals to fund development. This is a hidden gem.

NoRisksNoFun Posted - 2 weeks ago

$TGTX $what about $auph and $VYGR

Goblinvomit Posted - 2 weeks ago

$VYGR oof not great results from UCB anti Tau. https://firstwordpharma.com/story/5908501

6k_investor Posted - 10/31/24

$CYCN is a tiny $7M Market Cap Penny Stock with $4.5M Cash that hasn’t diluted at all in the last year and has ZERO DILUTION Filings. ZERO DEBT. Trading with a TINY 2M share float. 👇*MUST SEE DD BELOW*👇 This company is ran by VERY high power executives with a very impressive track record. You won’t find another Biotech penny stock with an $8M valuation that has this kind of leadership. The new CEO (Regina Graul) appointed in August was the Vice President of $EQRx which got bought out for $950M. Peter Hecht, PhD - The current director / strategic advisor and EX CEO of $CYCN founded $IRWD (Currently a $654M Company) it was trading over a $3 Billion Dollar Valuation in 2018! (Peter was the CEO of $IRWD from 1998 to 2019) Another director of $CYCN - Errol De Souza, PhD, founded $NBIX Neurocrine Biosciences Inc (A $12 BILLION DOLLAR COMPANY) trading at $120 per share. Another director of the company - Michael Higgins served as Interm CEO of $VYGR currently a $368M company.

NoRisksNoFun Posted - 10/30/24

$ARVN %70 revenue surprise $VKTX $ibrx $NMRA $VYGR

juicy123 Posted - 10/29/24

$VYGR how much will this run up if there is an earnings beat?

juicy123 Posted - 10/28/24

$VYGR 5 straight days of green tomorrow or no?

RallyRaider Posted - 10/28/24

$VYGR go go